Skip to content

Clinical Evaluation of Two Daily Disposable Silicone Hydrogel Contact Lenses

Clinical Evaluation of Two Daily Disposable Silicone Hydrogel Contact Lenses

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01561560
Enrollment
123
Registered
2012-03-23
Start date
2012-05-31
Completion date
2012-08-31
Last updated
2014-01-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Keywords

DAILIES TOTAL1, contact lenses, myopia

Brief summary

The purpose of this crossover study was to evaluate the end-of-day comfort of two commercially available, daily disposable, silicone hydrogel contact lenses.

Interventions

CE-marked, silicone hydrogel, soft contact lenses for daily wear, daily disposable use, worn bilaterally for two weeks in either Period One or Period Two

CE-marked, silicone hydrogel, soft contact lenses for daily wear, daily disposable use, worn bilaterally for two weeks in either Period One or Period Two

Sponsors

Alcon Research
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Sign written Informed Consent Document. * Currently wearing soft contact lenses in both eyes and identified as symptomatic based on questionnaire responses. * Currently wearing either daily disposable contact lenses or weekly/monthly replacement contact lenses. * Able to achieve visual acuity of at least 6/7.5 in each eye with study lenses in the available parameters. * Willing to wear study lenses for at least eight hours per day and at least five days per week. * Other protocol-defined inclusion criteria may apply.

Exclusion criteria

* Has not worn contact lenses before. * Currently wearing DAILIES TOTAL1 or 1-DAY ACUVUE TRUEYE contact lenses. * Any systemic or ocular disease or disorder that would negatively affect the conduct or outcome of the study. * Ocular surgery/trauma within the last six months. * Topical ocular or systemic use of antibiotics within seven days of enrollment. * Pregnant or nursing women. * Other protocol-defined

Design outcomes

Primary

MeasureTime frameDescription
End-of-day ComfortWeek 2End-of-day comfort was interpreted and reported by the participant on a questionnaire as a single, retrospective measurement of two weeks of wear. Participants were asked, Please rate the study lenses you have been wearing the in the following area: End-of-day comfort and recorded their response on a continuous 1-10 Likert scale (1=poor and 10=excellent).

Countries

United States

Participant flow

Recruitment details

Participants were recruited from two study centers in Finland, three study centers in German, and three study centers in the UK.

Pre-assignment details

Of the 123 participants enrolled, two were excluded prior to randomization. This reporting group includes all participants enrolled and exposed to Test Article (121).

Participants by arm

ArmCount
OVERALL
Delefilcon A contact lenses and narafilcon A contact lenses worn in randomized order. Each product was worn bilaterally on a daily wear, daily disposable basis for two weeks.
121
Total121

Withdrawals & dropouts

PeriodReasonFG000FG001
First Two Weeks of WearAdverse Event01
First Two Weeks of WearTime/job conflict01
Second Two Weeks of WearAdverse Event01

Baseline characteristics

CharacteristicOVERALL
Age, Continuous34.0 years
STANDARD_DEVIATION 10.4
Sex: Female, Male
Female
85 Participants
Sex: Female, Male
Male
36 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 1190 / 121
serious
Total, serious adverse events
0 / 1190 / 121

Outcome results

Primary

End-of-day Comfort

End-of-day comfort was interpreted and reported by the participant on a questionnaire as a single, retrospective measurement of two weeks of wear. Participants were asked, Please rate the study lenses you have been wearing the in the following area: End-of-day comfort and recorded their response on a continuous 1-10 Likert scale (1=poor and 10=excellent).

Time frame: Week 2

Population: This reporting group includes all participants who finished the study, minus any major protocol deviations as determined by masked review.

ArmMeasureValue (MEAN)Dispersion
DAILIES TOTAL1End-of-day Comfort8.3 Units on a scaleStandard Deviation 1.91
TRUEYEEnd-of-day Comfort6.6 Units on a scaleStandard Deviation 2.22

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026